04:12 PM EDT, 06/14/2024 (MT Newswires) -- Andy Sassine, Director, Chief Financial Officer, on June 12, 2024, sold 50,000 shares in Arcturus Therapeutics Holdings ( ARCT ) for $1,601,500. Following the Form 4 filing with the SEC, Sassine has control over a total of 220,526 shares of the company, with 220,526 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1768224/000119380524000801/xslF345X03/e663716_4-sassine.xml